临床外科杂志 ›› 2024, Vol. 32 ›› Issue (7): 757-761.doi: 10.3969/j.issn.1005-6483.2024.07.023

• 论著 • 上一篇    下一篇

膀胱癌病人血清miR-143-3p、ATG2B水平与临床病理及预后生存的关系

路慧青 赵友为 刘巍   

  1. 050011 石家庄市第三医院胸外科(路慧青),泌尿外科(刘巍);河北医科大学第一医院泌尿外科(赵友为)
  • 收稿日期:2023-05-12 出版日期:2024-07-20 发布日期:2024-07-20

Correlation of serum miR-143-3p and ATG2B levels with clinicopathology and postoperative survival in patients with radical cystectomy

LU Huiqing,ZHAO Youwei,LIU Wei   

  1. Department of Thoracic Surgery,Shijiazhuang Third Hospital,Shijiazhuang,Hebei 050011,China
  • Received:2023-05-12 Online:2024-07-20 Published:2024-07-20

摘要: 目的 探讨miR-143-3p、ATG2B在膀胱癌病人血清中的表达及其与临床病理和病人预后的关系。方法 2017年1月~2019年1月在我院进行膀胱癌根治术的病人88例为研究组,本院行健康体检的志愿者80例为对照组。实时荧光定量PCR(qRT-PCR)法检测病人术前、术后4周静脉血miR-143-3p、ATG2B水平;pearson分析二者的相关性。通过受试者工作特征(ROC)曲线评估miR-143-3p、ATG2B对膀胱癌的预测价值。用Kaplan-Meier法绘制生存曲线;通过多因素Cox回归分析膀胱癌根治术病人预后的影响因素。结果 miR-143-3p在膀胱癌病人血清中表达水平较对照组降低(0.68±0.12 vs. 0.87±0.26),ATG2B表达水平升高(1.02±0.30 vs. 0.61±0.18),差异有统计学意义(P<0.05);病人术后血清中miR-143-3p水平较术前升高(0.77±0.23 vs. 0.68±0.12),ATG2B水平较术前降低(0.85±0.26 vs. 1.02±0.30),差异有统计学意义(P<0.05);研究组miR-143-3p与ATG2B表达呈负相关(rZ=-0.454,rZ=-0.407,P<0.01);miR-143-3p对膀胱癌的诊断AUC为0.846(95%CI:0.783~0.897),敏感度、特异度分别为79.55%、78.75%;ATG2B对膀胱癌诊断AUC为0.883(95%CI:0.824~0.927),敏感度、特异度分别为78.41%、81.25%;二者联合诊断膀胱癌的AUC为0.939(95%CI:0.891~0.970),敏感度、特异度分别为87.50%、88.75%。miR-143-3p低表达组3年生存率(34.88%,15/43)低于高表达组(77.78%,35/45),ATG2B高表达组3年生存率(40.91%,18/44)低于低表达组(72.73%,32/44),差异有统计学意义(Log-rank χ2=18.055,8.658,P=0.000,0.003)。多因素Cox回归分析表明,淋巴结转移、远处转移、肿瘤病理分级、TNM分期、miR-143-3p、ATG2B是膀胱癌病人生存状况的影响因素。结论 膀胱癌病人血清中miR-143-3p呈低表达,ATG2B呈高表达,二者表达与膀胱癌病人临床病理特征和预后密切相关。

关键词: 膀胱癌, miR-143-3p, ATG2B, 临床病理特征, 预后

Abstract: Objective To investigate the expression of miR-143-3p and ATG2B in serum of patients with bladder cancer and their relationship with clinicopathology,prognosis and survival of patients.Methods Eighty-eight patients who underwent radical bladder cancer surgery in our hospital from January 2017 to January 2019 were regarded as the research group,and 80 volunteers who underwent physical examination in our hospital were included as the control group.Quantitative real-time PCR (qRT-PCR) method was performed to detect the levels of miR-143-3p and ATG2B;The predictive value of miR-143-3p and ATG2B for bladder cancer was evaluated by ROC curve.Draw survival curve using Kaplan Meier method;The prognostic factors of bladder cancer patients were analyzed by Cox regression.Results The expression level of miR-143-3p in the serum of bladder cancer patients was lower than that in the control group (0.68±0.12 vs. 0.87±0.26),and the expression level of ATG2B was higher (1.02±0.30 vs. 0.61±0.18) (P<0.05);the expression level of miR-143-3p in serum of postoperative patients was higher than that before operation (0.77±0.23 vs. 0.68±0.12),and the expression level of ATG2B was lower than that before operation (0.85±0.26 vs. 1.02±0.30) (P<0.05);The study group showed a negative correlation between miR-143-3p and ATG2B expression (r=-0.454,r=-0.407,P<0.01);The AUC of miR-143-3p in the diagnosis of bladder cancer was 0.846 (95%CI:0.783-0.897),the sensitivity and specificity were 79.55% and 78.75% respectively;The AUC of ATG2B in the diagnosis of bladder cancer was 0.883 (95%CI:0.824-0.927),the sensitivity and specificity were 78.41% and 81.25% respectively;The AUC for the diagnosis of bladder cancer was 0.939 (95%CI:0.891-0.970),the sensitivity and specificity were 87.50% and 88.75%,respectively.The 3-year survival rate of the miR-143-3p low expression group was 34.88% (15/43) lower than that of the high expression group 77.78% (35/45),and the 3-year survival rate of the ATG2B high expression group was 40.91% (18/44) lower than that of the low expression group 72.73% (32/44).The differences were statistically significant (Log rank χ2=18.055,8.658,P=0.000,0.003).Lymph node metastasis,distant metastasis,tumor pathological grade,TNM stage,miR-143-3p,ATG2B are all factors influencing the survival of bladder cancer patients.Conclusion The serum expression of miR-143-3p in patients with bladder cancer is low,and the expression of ATG2B is high,and the expressions of the two are closely related to the clinicopathological characteristics and prognosis of patients with bladder cancer.

Key words: bladder cancer, miR-143-3p, ATG2B, clinicopathological features, prognosis

[1] 何朝滨 李升平. 不可逆电穿孔治疗胰腺癌[J]. 临床外科杂志, 2024, 32(7): 673-676.
[2] 徐业成 傅德良. 胰腺全切除术在胰腺癌治疗中的应用[J]. 临床外科杂志, 2024, 32(7): 677-679.
[3] 黄如敬 鲁洪岭 吴超 杨洪娟 尹晓明 赵阳 康华薇 田菲 孙云川. 非小细胞肺癌病人血清miR-326和miR-623表达与临床病理特征及预后的关系[J]. 临床外科杂志, 2024, 32(7): 706-710.
[4] 冯南 林鸿千 郭义锦 王亚娇. 食管印戒细胞癌病人预后不良危险因素分析及列线图预测模型构建[J]. 临床外科杂志, 2024, 32(7): 712-715.
[5] 尹英爱 秦桂萍 华玉兰 曹敏 齐淋喆 白苏日娜 杨悦. 伴AFP明显升高的高级别胎儿型肺腺癌一例[J]. 临床外科杂志, 2024, 32(6): 619-620.
[6] 孙杨 王豪 马腾 刘永吉 苗丹 石岭. 静脉溶栓联合Trevo支架机械取栓治疗缺血性脑卒中的疗效及影响因素分析[J]. 临床外科杂志, 2024, 32(5): 468-471.
[7] 秦飞 李帆. 重型颅脑损伤病人血清微小RNA-542-3p、长链非编码RNA牛磺酸上调基因1表达及其与预后的关系[J]. 临床外科杂志, 2024, 32(5): 472-475.
[8] 李萌 倪乾洋 于溯洋 张燕 李红岩. 结直肠癌中整合素α-5、β-1、β-2表达的意义及其评估预后的价值[J]. 临床外科杂志, 2024, 32(5): 502-505.
[9] 王福荣 郝富永 胡春江 张海矿 孔翔飞. 创伤指数评分联合C反应蛋白/白蛋白[J]. 临床外科杂志, 2024, 32(4): 373-376.
[10] 张海静 牛三强 白宝琴. 癌组织FOXP1、CHI3L1表达与分化型甲状腺癌病人临床病理因素及预后的关系[J]. 临床外科杂志, 2024, 32(4): 381-384.
[11] 黄宏伟 程琪 廖威 张凯悦 王豪 梅斌. 中国肝癌分期Ⅲa期巨大肝癌术后辅助免疫治疗的疗效分析[J]. 临床外科杂志, 2024, 32(4): 386-390.
[12] 唐佳艳 毛甜甜 张敏 钟莹. 血清微小RNA-325-3p和成纤维细胞生长因子10表达水平对急性胰腺炎病情及预后评估的价值[J]. 临床外科杂志, 2024, 32(4): 401-405.
[13] 林勇 赵占学. 叉头框蛋白M1和程序性细胞死亡受体1配体在胃癌组织中的表达及其与临床预后的相关性研究[J]. 临床外科杂志, 2024, 32(4): 417-420.
[14] 沈辉 云天奇 代伟宏. 急危重多发伤胃肠破裂急诊修复术后不良预后风险预测模型的构建与验证[J]. 临床外科杂志, 2024, 32(4): 425-428.
[15] 廖汉琪 唐羿 胡凯 姜耕. 贲门癌组织FOXC1、SOX11表达及与病人临床病理特征和预后的关系[J]. 临床外科杂志, 2024, 32(3): 293-297.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 昌盛. 中国心脏死亡捐献供肾器官的维护[J]. 临床外科杂志, 2016, 24(10): 744 .
[2] 杨华;李新长;龙成美;等. 公民逝世后器官捐献供肾移植临床分析[J]. 临床外科杂志, 2016, 24(10): 747 .
[3] 肖国栋;刘国辉. 跗骨窦切口联合经皮置钉技术微创治疗跟骨骨折的临床疗效分析[J]. 临床外科杂志, 2016, 24(10): 783 .
[4] 胡光俊;宋晓阳;陶军. 右美托咪定添加到罗哌卡因中对腰丛坐骨神经阻滞及镇静的影响[J]. 临床外科杂志, 2016, 24(10): 796 .
[5] 贺长林;黎秋曦;刘锋;等. 腹腔镜阑尾切除术中转开腹及再手术的处理体会[J]. 临床外科杂志, 2016, 24(10): 802 .
[6] 方军;余阳;许涛;等. 小野寺营养预后指数在胃癌患者预后评估中的价值[J]. 临床外科杂志, 2016, 24(11): 831 .
[7] 周力;王晓辉;李小军;等. 腹腔镜下治疗直肠癌同时伴右半结肠癌手术体会[J]. 临床外科杂志, 2016, 24(11): 848 .
[8] 沙米尔;丁佑铭;汪斌;等. 腹腔镜联合胆道镜两种术式治疗胆囊结石合并胆总管结石的临床疗效比较[J]. 临床外科杂志, 2016, 24(11): 872 .
[9] 严文波;潘伟华;武志祥;等. 新生儿先天性腹裂外科处理后转归[J]. 临床外科杂志, 2016, 24(11): 879 .
[10] 戴玮;邱建平;高泉根;等. 腹膜前间隙修补术在股疝治疗中的应用[J]. 临床外科杂志, 2016, 24(11): 826 .